Drug Enforcement Administration October 28, 2009 – Federal Register Recent Federal Regulation Documents
Results 1 - 26 of 26
Schedules of Controlled Substances: Placement of 5-Methoxy-N,N-Dimethyltryptamine Into Schedule I of the Controlled Substances Act
On August 21, 2009, the Drug Enforcement Administration (DEA) published a notice of proposed rulemaking in the Federal Register, 74 FR 42217, to place the substance 5-methoxy-N,N-dimethyltryptamine (5- MeO-DMT) and its salts into schedule I of the Controlled Substances Act (CSA). The original 30-day comment period expired on September 21, 2009. DEA is reopening the comment period for an additional 30-day period.
Registration Requirements for Individual Practitioners Operating in a “Locum Tenens” Capacity
On December 1, 2006, the Drug Enforcement Administration (DEA) published in the Federal Register a Final Rule ``Clarification of Registration Requirements for Individual Practitioners'' (71 FR 69478). The Final Rule makes it clear that when an individual practitioner practices in more than one State, he or she must obtain a separate DEA registration for each State. The Final Rule also noted that DEA would
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
